+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Aurinia Pharmaceuticals Inc (AUP) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals) is a clinical stage biopharmaceutical company which develops and commercializes therapies for the treatment of renal and autoimmune diseases. The company’s lead product candidate includes voclosporin, a novel therapeutic immunomodulating differentiated calcineurin inhibitor used for the treatment of lupus nephritis (LN), an inflammation of the kidney caused by systemic lupus erythematosus and nephrotic syndrome. Aurinia Pharmaceuticals' voclosporin is also used in indications such as prevention of rejection in renal transplantation. The company works in partnership with other pharmaceutical companies to develop and commercialize its existing pipeline. Aurinia Pharmaceuticals is headquartered in Victoria, British Columbia, Canada.

Aurinia Pharmaceuticals Inc Key Recent Developments

Feb 22, 2018: Aurinia Enhances Research, Development, and Scientific Expertise with the Appointment of Michael Hayden to its Board of Directors
Feb 20, 2018: Aurinia Named Company of the Year by LifeSciences BC
Feb 14, 2018: Aurinia Pharmaceuticals Launches New Lupus Nephritis Disease Awareness Program
Feb 08, 2018: Aurinia Enhances Commercial and Business Development Expertise with the Appointment of Joseph P. Hagan to its Board of Directors
Dec 11, 2017: Aurinia Pharmaceuticals Added to the NASDAQ Biotech Index

This comprehensive SWOT profile of Aurinia Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aurinia Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Aurinia Pharmaceuticals Inc - Key Information
  • Aurinia Pharmaceuticals Inc - Overview
  • Aurinia Pharmaceuticals Inc - Key Employees
  • Aurinia Pharmaceuticals Inc - Key Employee Biographies
  • Aurinia Pharmaceuticals Inc - Key Operational Heads
  • Aurinia Pharmaceuticals Inc - Major Products and Services
  • Aurinia Pharmaceuticals Inc - History
  • Aurinia Pharmaceuticals Inc - Company Statement
  • Aurinia Pharmaceuticals Inc - Locations And Subsidiaries
  • Aurinia Pharmaceuticals Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Aurinia Pharmaceuticals Inc - Business Description
  • Aurinia Pharmaceuticals Inc - Corporate Strategy
  • Aurinia Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Aurinia Pharmaceuticals Inc - Strengths
  • Aurinia Pharmaceuticals Inc - Weaknesses
  • Aurinia Pharmaceuticals Inc - Opportunities
  • Aurinia Pharmaceuticals Inc - Threats
  • Aurinia Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Aurinia Pharmaceuticals Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Aurinia Pharmaceuticals Inc, Key Information
  • Aurinia Pharmaceuticals Inc, Key Ratios
  • Aurinia Pharmaceuticals Inc, Share Data
  • Aurinia Pharmaceuticals Inc, Major Products and Services
  • Aurinia Pharmaceuticals Inc, History
  • Aurinia Pharmaceuticals Inc, Key Employees
  • Aurinia Pharmaceuticals Inc, Key Employee Biographies
  • Aurinia Pharmaceuticals Inc, Key Operational Heads
  • Aurinia Pharmaceuticals Inc, Other Locations
  • Aurinia Pharmaceuticals Inc, Subsidiaries
  • Aurinia Pharmaceuticals Inc, Key Manufacturing facilities
  • Aurinia Pharmaceuticals Inc, Key Competitors
  • Aurinia Pharmaceuticals Inc, SWOT Analysis
  • Aurinia Pharmaceuticals Inc, Ratios based on current share price
  • Aurinia Pharmaceuticals Inc, Annual Ratios
  • Aurinia Pharmaceuticals Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Aurinia Pharmaceuticals Inc, Performance Chart
  • Aurinia Pharmaceuticals Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3